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Outcome of elective endovascular abdominal
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Stuart B. Prenner, BS, Irene C. Turnbull, MD, Rajesh Malik, MD, Alexander Salloum, MD,
Sharif H. Ellozy, MD, Angeliki G. Vouyouka, MD, Michael L. Marin, MD, and Peter L. Faries, MD,
New York, NY
Objective: Compared to open repair of abdominal aortic aneurysms (AAA), endovascular aneurysm repair (EVAR) is
associated with decreased perioperative morbidity and mortality. This study sought to examine the outcomes of EVAR in
patients >80 years of age.
Methods: This was a retrospective review from a prospectively maintained computerized database. A total of 322 patients
aged >80 underwent elective EVAR from January 1997 to November 2007. Mean age was 84 years  3.4 years (range,
80-95 years), and 78.5% were male. Mean aneurysm size was 62 mm  12 mm (range, 39-110 mm).
Results: Mean procedural blood loss was 350 mL (range, 50-2700 mL), and 13.9% required intraoperative transfusion.
Mean length of postoperative stay was 2.46 days (median, 1 day; range, 1-42 days), with 54.3% of patients discharged on
the first postoperative day. There were 25 (7.8%) perioperative major adverse events. The most common were categorized
as device-related (6), cardiac (4), gastrointestinal (4), and bleeding/hematoma (3). The perioperative 30-day mortality
rate was 3.1% (10 of 322). Mean follow-up was 25.7 months (range, 1-110 months). Overall, 47 patients (14.6%)
required secondary intervention, 7 patients (2.2%) underwent conversion to open repair, and 4 patients (1.2%) died from
AAA rupture. Endoleaks occurred in 95 patients (29.4%), with 20 type I, 48 type II, and 27 of indeterminate type; of
these, 10 patients with type I endoleaks underwent secondary intervention. Freedom from all-cause mortality at 1 year
was 84.3% and at 5 years was 27.4%. Freedom from aneurysm-related mortality at 5 years was 92.9%.
Conclusion: EVAR in octogenarians is associated with high procedural success and low perioperative morbidity and
mortality. The midterm results of this study support the use of EVAR in this patient population. Further studies are
needed to predict short-term and long-term mortality risk, and treatment for other causes of death. (J Vasc Surg 2010;
51:1354-9.)Life expectancy in the western world is increasing. In
the United States, individuals over 80 years old currently
represent the fastest growing demographic of the popula-
tion and are expected to increase from 3.4 million in 1994
to 9 million by 2030.1,2 Therefore, the prevalence of ab-
dominal aortic aneurysms (AAA), an age-related disease, is
likely to continue to increase in this population. Currently,
elective treatment of AAA is achieved by either open surgi-
cal repair or endovascular aneurysm repair (EVAR). Re-
gardless of the chosen technique, patients over 80 years of
age experience higher rates of perioperative morbidity and
mortality and decreased 5-year survival compared with their
younger counterparts.3-5 For patients undergoing EVAR,
age 80 was found to be an independent factor for higher
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1354mortality and endoleak.4 AAAs in the elderly population
are of particular concern. Many individuals over 80 are
excluded from studies on AAA and are not considered for
open surgical repair because of their age and comorbidi-
ties.4 Yet, one recent study showed that compared with
untreated AAAs, open repair of AAAs in octogenarians was
associated with significantly increased life expectancy.6 The
purpose of this study was to report a single institution’s
experience with elective EVAR in octogenarians and nona-
genarians.
METHODS
This study was a retrospective review of a prospectively
collected database. Patients were included in the study if
they underwent elective EVAR between January 1997 and
November 2007 and were 80 years or older at the time of
the procedure. The study was approved by the institution’s
internal review board. All EVAR procedures were per-
formed at the Mount Sinai Hospital, New York, NY. Pa-
tients were excluded if they had undergone a previous
EVAR at age 80. Postoperatively, clinical pathways were
instituted to streamline hospital management. Primary
endpoints consisted of outcomes evaluating technical suc-
cess, perioperative morbidity and mortality, and long-term
outcomes on aneurysm-related mortality. Secondary end-
points included EVAR and stent graft-related complica-
JOURNAL OF VASCULAR SURGERY
Volume 51, Number 6 Prenner et al 1355tions: presence of endoleak, aneurysm expansion, stent
graft migration, AAA rupture, secondary interventions, and
conversion to open repair.
The Talent stent graft (Minneapolis, Minn) was the
preferred device given its availability in a wide array of graft
diameters and length configurations, making it amenable to
a large range of patient anatomy. However, a significant
proportion of patients were treated outside the instructions
for use for the Talent device. The majority of these patients
were enrolled before Food & Drug Administration ap-
proval and, therefore, no instructions for use was available
to guide treatment recommendations.
Preoperative aneurysm size and anatomic character-
istics were determined with computed tomography (CT)
angiography. Postoperatively, patients were followed at
1, 6, and 12 months, and annually thereafter, with a
standardized follow-up protocol that included physical
examination, helical CT angiography, and plain abdom-
inal radiographs. No decline in renal function was attrib-
utable to the contrast required for CT. Alternative tech-
niques were utilized in patients with renal insufficiency.
Endoleaks were detected by CT scan and were reported
as primary endoleaks if they occurred within the periop-
erative period (30 days), and otherwise as secondary
endoleaks. For the analysis of freedom from endoleak,
the event was considered as present from the first time
that the endoleak was detected, regardless of whether the
endoleak continued, resolved spontaneously, or required
intervention. Graft migration was defined by distal dis-
placement of the stent graft of 10 mm or more. Graft
breakage and migration were identified by plain abdom-
inal radiographs, and migration was confirmed with CT
angiography. Graft patency was also determined with CT
angiography in the event of clinical or radiographic
evidence of thrombosis.
Technical success was defined as successful intravascu-
lar access to the site of the aneurysm, successful deployment
of the stent graft with secure fixation and patency, and
absence of either type I or III endoleak within the first 24
hours. Clinical success was defined as successful deploy-
ment of the device at the desired location without death,
type I or III endoleak, graft infection or thrombosis, aneu-
rysm expansion (5mm), aneurysm rupture, or conversion
to open repair.7
Analysis of data was based on the intention-to-treat
principle. Patients in whom EVAR failed and who under-
went immediate or late conversion to open surgery were
always included in the analysis. Results are reported as mean
and SD. Rates of freedom from overall death, aneurysm-
related death, secondary procedures, and other EVAR-
associated late outcomes were estimated with the Kaplan-
Meier method. Patients who were lost to follow-up are
reflected in the number at risk in the Kaplan-Meier curves.
All statistical analyses were conducted using SPSS software
(Chicago, Ill). Multivariable analysis was not feasible for
this patient population.RESULTS
A total of 322 patients aged 80 years or older who
underwent elective EVAR were included in the study. The
mean age was 84 years  3.4 years (range, 80-95 years),
78.5% were male, 301 were 80 to 90 years, and there
were 21 patients 90 years old. The mean follow-up time
was 25.7 months (range, 1-110 months). The mean max-
imum diameter of the aneurysm was 62 mm  12 mm
(range, 39-110 mm). The majority of patients had four
comorbidities, with hypertension and coronary artery dis-
ease the two most frequent, affecting 73.6% and 44.4% of
patients, respectively (Table I).
Regional anesthesia (spinal and epidural) was used in
the majority of cases (94.8%), with only 1.9% requiring
general anesthesia, and the rest (3.2%) were performed
under local anesthesia. The average duration of the proce-
dure was 237 minutes  95 minutes (80-748 minutes).
During the procedure, an average of 289 mL  126 mL
(80-855 mL) of contrast was used. The mean estimated
blood loss was 350 mL  316 mL (range, 50-2700 mL),
and the blood loss was1000mL in 8 cases. Intraoperative
transfusion was required in 45 events (13.9%; Table II). A
bifurcated device was used in 78.2% of the cases, 20.5% of
the patients were treated with an aortouni-iliac device, and
1.3% received a tube graft. A total of 69.6% received Talent
grafts, whereas the rest received other brands (Table III).
There were no device-specific complications. Mean length
of postoperative stay was 2 days  4 days (median, 1 day;
range, 1-42 days), with 54.3% of patients discharged on the
first postoperative day, and 14.2% on the second day after
the procedure. One patient remained in the hospital for 42
days. Seven patients required treatment in the intensive care
Table I. Preprocedural characteristics
Characteristic n  322
Demographics
Age, mean  SD, y 83.6  3.4
Gender (male), (%) 78.5
Risks (%)
Hypertension 73.6
Coronary artery disease 44.4
Angina 3.7
Arrhythmia 26.7
Myocardial infarction 24.2
Congestive heart failure 7.1
Chronic obstructive pulmonary disease 21.4
Hyperlipidemia 45.0
Creatinine 1.5 mg/dL 21.7
Peripheral vascular disease 9.3
Diabetes 10.9
Stroke 9.6
Smoking 63.4
Cancer 15.5
ASA 2 1.6
ASA 3 74.5
ASA 4 18.0
ASA, American Society of Anesthesiologists physical status classification.unit (ICU).
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95.7%. The 14 technical failures included two instances of
primary device failure. In one case, the contralateral limb
failed to deploy. In the second, the occluder deployed distal
to the desired level and was removed. There were three
instances of inability to deploy the device due to difficult
anatomy: two procedures were aborted, and one was con-
verted to open repair. Of the remaining nine failures, two
were the result of graft migration, three were the result of
graft thrombosis (all of which required a femoral-femoral
bypass), two were persistent type I endoleaks, and one case
of conversion to open repair after vessel injury. Finally,
there was one death within the first 24 hours after EVAR in
a patient with a history of atrial fibrillation who developed
mesenteric thrombosis. Etiology of the mesenteric throm-
bosis is unknown but is presumed to be related to manip-
ulation of intra-aortic content or embolization related to
the patient’s baseline atrial fibrillation.
There were 18 cases of intraoperative type I endoleak,
17 of which were proximal. Two cases of proximal endoleak
Table II. Procedural details
Procedural characteristic n  322
Aneurysm diameter  SD
(range), mm 61.8  11.6 (39-110)
Duration of procedure  SD
(range), min 237  95 (80-748)
Anesthesia
General 6/308 (1.9%)
Regional 292/308 (94.8%)
Local 10/308 (3.2%)
Procedural blood loss  SD
(range), mL 349.81  316.42 (50-2700)
Volume contrast  SD
(range), mL 288.78  125.97 (80-855)
Time until discharge  SD
(range), d 2.46  4.21 (1-41)
Time in ICU, d 7/288 (2.4%)a
Follow-up, mean (range), mo 25.7 (1-110)
ICU, Intensive care unit.
aNumber of patients who spent any time in an ICU setting.
Table III. Device information
Configuration N  312 (%)a
Aortouni-iliac 64 (20.5)
Bifurcated 244 (78.2)
Tube 4 (1.3)
Brand n  309 (%)a
Ancure (Guidant) 4 (1.3)
AneuRx (Medtronic) 23 (7.4)
Fortron (Cordis, Inc) 6 (1.9)
Gore Excluder (Gore Medical) 57 (18.4)
Talent (Medtronic) 215 (69.6)
Zenith (Cook Medical) 4 (1.3)
aDenominator indicating cases with available device information.did not resolve despite subsequent cuff extension. Oneproximal endoleak was fixed with a Palmaz stent (Warren,
NJ). There were two cases of acute device migration dis-
tally; in the first case, the graft was deployed successfully but
descended into the aneurysm sac immediately after a bal-
looning attempt of the proximal attachment site. The sec-
ond migration event was fixed intraoperatively with proxi-
mal cuff extension. Both cases of migration occurred with
Talent grafts – one bifurcated and one aortouni-iliac.
The perioperative mortality rate was 3.1% (10 events)
with one death within the first 24 hours, as described
above. The cause of death in the remaining nine events
included: four cardiac complications, one respiratory fail-
ure, one intracranial hemorrhage, one event of sepsis (un-
related to the graft), and two cases of cardiac arrest. There
were no perioperative deaths in patients who were con-
verted to open repair.
The clinical success rate at 30 days was 88.2%, with type
I endoleaks responsible for the greatest number of clinical
failures. There were 25 major adverse events within the
30-day perioperative period. Three patients developed
ischemic colitis, two of whom required subsequent subtotal
colectomies. All cases of ischemic colitis were due to de-
creased perfusion of the sigmoid colon. Other significant
perioperative events included two cases of myocardial in-
farction, neither of which was fatal, and two cases of acute
renal failure, one of which necessitated temporary hemodi-
alysis. The etiology of the renal failure could not be distin-
guished in either case, and is presumed to be related to
either contrast-induced nephropathy or embolization and
ischemia to the renal parenchyma. Overall, 25 patients had
one or more complications (Table IV).
The overall freedom from secondary reintervention
(including coil embolization, cuff extension, conversion to
open repair, and femoral-femoral bypass) was 92.1% at 1
year and 70.8% at 5 years (Fig 1). The most common
secondary interventions included: cuff extension for type I
endoleaks and coil embolization for type II endoleaks
(Table V). Overall, there were two intraoperative, one
Table IV. Perioperative adverse events
Complications n %
Access site and lower limb ischemia 2 0.6
Bleeding/hematoma 3 0.9
Device-related 6 1.9
Cardiac 4 1.2
Gastrointestinal 4 1.2
Renal 2 0.6
Respiratory 2 0.6
Cerebral 1 0.3
Other 1 0.3
n, Number.
Bleeding includes one event of intracranial hemorrhage. Cardiac includes
angina, arrhythmia, and myocardial infarction. Gastrointestinal includes
ischemic colitis and ileus. Renal includes renal insufficiency (creatinine
1.5). Respiratory includes pneumonia and respiratory failure. Cerebral
includes transient ischemic attack. Other includes a case of urinary retention.perioperative, and four late conversions to open repair.
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year and 92.9% at 5 years (Fig 2). Freedom from all cause
mortality at 1 year was 84.3% and at 5 years was 27.4% (Fig
3). Overall, there were 16 AAA-related deaths. By defini-
tion, this included all 10 perioperative deaths regardless of
cause; the other causes of death included two cases of sepsis
and four events of AAA rupture. The rate of freedom from
Fig 1. Kaplan-Meier graph represents freedom from secondary
intervention, including coil embolization, cuff extension, conver-
sion to open repair, and femoral-femoral bypass.
Table V. Secondary interventions
Indication n  322 %
Conversion to open 3 0.9
Femoral-femoral bypass 8 2.4
Cuff extension 16 4.9
Coil embolization 14 4.3
Axillary-femoral bypass 2 0.6
Iliofemoral thrombectomy 2 0.6
Other 2 0.6
Fig 2. Kaplan-Meier graph represents freedom from abdominal
aortic aneurysm (AAA)-related mortality including all periopera-
tive deaths, deaths from AAA rupture, and death due to secondary
intervention.endoleak was 73.7% at 1 year, and 54.8% at 5 years (Fig 4).Endoleaks occurred in 95 patients (29.4%), with 20 type I,
48 type II, and 27 of indeterminate type (Table VI). All
type 1 endoleaks which were amenable to reintervention
(10 patients) were treated. The remainder of patients in
Fig 3. Kaplan-Meier graph represents freedom from all cause
mortality.
Fig 4. Kaplan-Meier graph represents freedom from type I and
type II endoleaks, and those of indeterminate types.
Table VI. Overall outcomes at 5 years
Events n %
Mortality 153 72.6
AAA-related mortality 16 7.1
Conversion 7 2.2
Rupture 4 1.2
Endoleaksa
Type I 20 6.2
Type II 48 14.9
Indeterminate type 27 8.4
Aneurysm growth 5 mm 71 22.0
AAA, Abdominal aortic aneurysm.
aEndoleaks refer to presence of endoleak regardless of whether endoleak was
ultimately treated.whom endovascular management of type I endoleak was
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not tolerate open repair due to medical comorbidities, were
followed. The rate of freedom from conversion to open
repair was 99.3% at 1 year and 96.7% at 5 years (SE, 0.005
and 0.014, respectively).
DISCUSSION
For octogenarians, the decision of how to repair an
AAA is often difficult, as this patient population often has
numerous major comorbidities that place them at a
higher risk when undergoing surgical repair.8 Age alone
may be a predictor of poor outcome with major elective
surgery, with one report finding that individuals 80 years
old compared with patients 65 to 69 had a twofold
higher operative mortality.9 According to one study,
34.3% of octogenarians undergoing open AAA repair
experience at least one major complication, compared to
18.8% for individuals 51 to 60 years old.10 As a result,
many octogenarians are deemed unfit for undergoing
open repair.10 Unfortunately, the 3-year survival for
octogenarians turned down for open repair is 17%, with
half of all deaths attributable to rupture.11 When open
techniques are used, octogenarians experience increased
rates of procedure-related mortality: the mortality for
patients in the sixth decade is 2.2% but rises to 7.3% for
patients in the eighth decade.12 In contrast to open
repair, EVAR may be performed under regional anesthe-
sia, and is an advisable alternative of treatment for pa-
tients considered at high risk for open repair.13,14
Compared to previous studies of open repair of AAAs in
octogenarians, patients who underwent EVAR in this study
had significantly higher rates of nearly all comorbidities. In
particular, Haug et al15 reported rates of hypertension,
coronary artery disease, and arrhythmia among octogenar-
ians who underwent open repair to be 36.2%, 29.5%, and
15.2%, respectively, compared to 73.6%, 44.4%, and 26.7%
in this study. Aneurysm size was similar between octoge-
narians who underwent EVAR in this study (6.2 cm) and
individuals included in reports on open repair (6.5, 6.7, and
6.8 cm).5 However, different perioperative outcomes are
seen in octogenarians who undergo EVAR compared with
those who undergo open repair. Mean procedural blood
loss in this study was 350 mL compared to 2800 mL in
open repair, and was due nearly entirely to blood loss
during introduction of the stent graft to the arteriotomy.16
Only 1 patient (0.3%) in this study required ventilatory
support in the ICU greater than 1 day, compared to 13.3%
after open repair.16 Importantly, perioperative mortality in
this study is similar to other recent EVAR studies which
range from 1.9% to 5%; however, perioperative mortality in
open procedures ranges from 5% to 10%.4,5 Each of these
findings suggests an advantage for EVAR over open repair
in patients 80 years of age.
One potential pitfall of EVAR is difficult anatomy,
which is largely bypassed with an open surgical approach.
As a retrospective study, some selection bias was unavoid-
able as octogenarians with unsuitable anatomy were unable
to undergo EVAR, and thus were necessarily excluded. In arecent report, higher incidence of AAA involving the iliac
vessels was reported in octogenarians compared with
younger patients.4 Indeed, in this study, three of the tech-
nical failures were directly attributable to complicated anat-
omy: in 2 cases, the procedures were aborted, and in the
third, open conversion was required. There were also 18
acute type I endoleaks that required cuff extension intraop-
eratively, with 2 cases failing to resolve. Furthermore, there
were two instances of intraoperative migration, one of
which was ultimately fatal. The high number of type I
endoleaks in this study is likely due both to complicated
anatomy in this population, and the inclusion of first gen-
eration devices that are no longer used. Compared with
younger patients, procedure time, contrast load, and re-
quirement for transfusions were higher than cohorts of
younger patients who underwent EVAR.17,18 This may
also be related to complex anatomy in these older patients
that would have precluded their inclusion in other trials.
Additionally, this series dates back to the initial years of
EVAR, and includes a high percentage of aortouni-iliac
devices.
For octogenarians, one of the most important factors in
recovery is rapid return to baseline and prompt discharge
from the hospital. The elderly may have less reserve to
tolerate even minor complications.19 In one recent report,
octogenarians who underwent EVAR had a statistically
significant more rapid return to baseline despite a lower
quality of life at 6 months compared with patients under-
going open repair.20 However, the importance of rapid
recovery to baseline cannot be underestimated, as much of
the morbidity associated with open procedures occurs as a
result of the prolonged hospital course that these individ-
uals require. In one report, 36% of individuals who under-
went open repair of AAA did not return to baseline, and
18% stated that if given the option, they would not have
undergone the procedure.21 Thus, some have argued that
even though EVAR is more often associated with secondary
interventions compared to open repair, the lower rate of
postoperative complications may outweigh the risk of ad-
ditional procedures.19 We report a very low rate of major
adverse events with EVAR in octogenarians, similar to
those in other studies. Additionally, we report a limited rate
of secondary procedures.
The disparity between freedom from aneurysm-related
mortality and overall mortality at 5 years suggests over-
whelmingly that octogenarians who undergo EVAR are
protected at least up to 5 years from aneurysm-related
death. However, given the life expectancy of this popula-
tion in light of their age and comorbidities, it is not surpris-
ing that the freedom from overall mortality at 5 years is
27.4%. Due to the extensive comorbidities in this patient
population, there is no widely accepted patient survival
curve for baseline comparison. Therefore, further studies
are needed to stratify risk based on comorbidities to better
predict which EVAR patients are likely to do well both in
the short-term and long-term.
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Our data show that EVAR in octogenarians is associ-
ated with low rates of perioperativemorbidity andmortality
and low long-term aneurysm-related mortality despite the
high rates of comorbidities in these patients. The lower
rates of perioperative adverse events and reduced hospital
stay may be of significant benefit to this population. We
conclude that EVAR is an appropriate option for the treat-
ment of AAA in individuals who have reached 80 years of
age.
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